The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Amiobeta     (2-butylbenzofuran-3-yl)-[4- (2...

Synonyms: Kordaron, Amiodarex, Amiohexal, Corbionax, Cordarone, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of L 3428


Psychiatry related information on L 3428


High impact information on L 3428


Chemical compound and disease context of L 3428


Biological context of L 3428


Anatomical context of L 3428


Associations of L 3428 with other chemical compounds


Gene context of L 3428


Analytical, diagnostic and therapeutic context of L 3428


  1. Amiodarone to prevent recurrence of atrial fibrillation. Furmaga, E.M., Good, C.B. N. Engl. J. Med. (2000) [Pubmed]
  2. Images in clinical medicine. Amiodarone-induced pulmonary toxicity. Olshansky, B. N. Engl. J. Med. (1997) [Pubmed]
  3. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. Heger, J.J., Prystowsky, E.N., Jackman, W.M., Naccarelli, G.V., Warfel, K.A., Rinkenberger, R.L., Zipes, D.P. N. Engl. J. Med. (1981) [Pubmed]
  4. More on amiodarone for ventricular tachyarrhythmias. Nademanee, K., Singh, B.H. N. Engl. J. Med. (1982) [Pubmed]
  5. Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. Yiu, K.H., Jim, M.H., Siu, C.W., Lee, C.H., Yuen, M., Mok, M., Shea, Y.F., Fan, K., Tse, H.F., Chow, W.H. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  6. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Julian, D.G., Camm, A.J., Frangin, G., Janse, M.J., Munoz, A., Schwartz, P.J., Simon, P. Lancet (1997) [Pubmed]
  7. Ocular adverse effects associated with systemic medications : recognition and management. Santaella, R.M., Fraunfelder, F.W. Drugs (2007) [Pubmed]
  8. Intravenous amiodarone in the treatment of refractory arrhythmias. Alves, L.E., Rose, E.P., Cahill, T.B. Crit. Care Med. (1985) [Pubmed]
  9. Long-term results of amiodarone therapy. Herre, J.M., Sauve, M.J., Scheinman, M.M. Clinical cardiology. (1987) [Pubmed]
  10. Neurotoxicity in rats following subchronic amiodarone treatment. Rao, K.S., Fernando, J.C., Ho, I.K., Mehendale, H.M. Res. Commun. Chem. Pathol. Pharmacol. (1986) [Pubmed]
  11. Images in clinical medicine. Pigmentation related to amiodarone. High, W.A., Weiss, S.D. N. Engl. J. Med. (2001) [Pubmed]
  12. Amiodarone in out-of-hospital cardiac arrest. Ballew, K.A., Philbrick, J.T. N. Engl. J. Med. (2000) [Pubmed]
  13. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M.J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., Nattel, S., Thibault, B. N. Engl. J. Med. (2000) [Pubmed]
  14. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. Kudenchuk, P.J., Cobb, L.A., Copass, M.K., Cummins, R.O., Doherty, A.M., Fahrenbruch, C.E., Hallstrom, A.P., Murray, W.A., Olsufka, M., Walsh, T. N. Engl. J. Med. (1999) [Pubmed]
  15. The effects of amiodarone on the thyroid. Martino, E., Bartalena, L., Bogazzi, F., Braverman, L.E. Endocr. Rev. (2001) [Pubmed]
  16. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Hohnloser, S.H., Kuck, K.H., Lilienthal, J. Lancet (2000) [Pubmed]
  17. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone. Paul, V., Griffith, M., Ward, D.E., Camm, A.J. Lancet (1989) [Pubmed]
  18. Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Disch, D.L., Greenberg, M.L., Holzberger, P.T., Malenka, D.J., Birkmeyer, J.D. Ann. Intern. Med. (1994) [Pubmed]
  19. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. Daoud, E.G., Strickberger, S.A., Man, K.C., Goyal, R., Deeb, G.M., Bolling, S.F., Pagani, F.D., Bitar, C., Meissner, M.D., Morady, F. N. Engl. J. Med. (1997) [Pubmed]
  20. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh, S.N., Fletcher, R.D., Fisher, S.G., Singh, B.N., Lewis, H.D., Deedwania, P.C., Massie, B.M., Colling, C., Lazzeri, D. N. Engl. J. Med. (1995) [Pubmed]
  21. Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. Gloor, H.O., Urthaler, F., James, T.N. J. Clin. Invest. (1983) [Pubmed]
  22. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. Norman, M.F., Lavin, T.N. J. Clin. Invest. (1989) [Pubmed]
  23. An increase in plasma cholesterol independent of thyroid function during long-term amiodarone therapy. A dose-dependent relationship. Wiersinga, W.M., Trip, M.D., van Beeren, M.H., Plomp, T.A., Oosting, H. Ann. Intern. Med. (1991) [Pubmed]
  24. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Toivonen, L., Kadish, A., Morady, F. Circulation (1991) [Pubmed]
  25. Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone. Zhang, Y.Q., Rao, R. J. Biol. Chem. (2007) [Pubmed]
  26. Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. Gupta, S.S., Ton, V.K., Beaudry, V., Rulli, S., Cunningham, K., Rao, R. J. Biol. Chem. (2003) [Pubmed]
  27. Potentially significant drug interactions of class III antiarrhythmic drugs. Yamreudeewong, W., DeBisschop, M., Martin, L.G., Lower, D.L. Drug safety : an international journal of medical toxicology and drug experience. (2003) [Pubmed]
  28. Induction of c-jun and TGF-beta 1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis. Chung, W.H., Bennett, B.M., Racz, W.J., Brien, J.F., Massey, T.E. Am. J. Physiol. Lung Cell Mol. Physiol. (2001) [Pubmed]
  29. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Fabre, G., Julian, B., Saint-Aubert, B., Joyeux, H., Berger, Y. Drug Metab. Dispos. (1993) [Pubmed]
  30. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Ohyama, K., Nakajima, M., Suzuki, M., Shimada, N., Yamazaki, H., Yokoi, T. British journal of clinical pharmacology. (2000) [Pubmed]
  31. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. Gosselink, A.T., Crijns, H.J., Van Gelder, I.C., Hillige, H., Wiesfeld, A.C., Lie, K.I. JAMA (1992) [Pubmed]
  32. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions. Larsen, G.C., Stupey, M.R., Walance, C.G., Griffith, K.K., Cutler, J.E., Kron, J., McAnulty, J.H. JAMA (1994) [Pubmed]
  33. Thyroidectomy for amiodarone-induced thyrotoxicosis. Farwell, A.P., Abend, S.L., Huang, S.K., Patwardhan, N.A., Braverman, L.E. JAMA (1990) [Pubmed]
WikiGenes - Universities